| Boston Scientific AVVIGO+ Multi-Modality Guidance System, AVVIGO + INT SYSTEM EU + ROW; the system utilizes an interactive display to provide phy…Z-0098-2025 · DQK | Boston Scientific Corporation | Recall | Oct 16, 2024FDA classification date |
| Boston Scientific AVVIGO+ Multi-Modality Guidance System, AVVIGO + INT SYSTEM JAPAN; the system utilizes an interactive display to provide physic…Z-0099-2025 · DQK | Boston Scientific Corporation | Recall | Oct 16, 2024FDA classification date |
| Boston Scientific AVVIGO+ Multi-Modality Guidance System, AVVIGO + INT SYSTEM US; the system utilizes an interactive display to provide physician…Z-0100-2025 · DQK | Boston Scientific Corporation | Recall | Oct 16, 2024FDA classification date |
| Boston Scientific AVVIGO+ Multi-Modality Guidance System, AVVIGO + MOB SYSTEM - ZERO COST EU + RO; the system utilizes an interactive display to …Z-0101-2025 · DQK | Boston Scientific Corporation | Recall | Oct 16, 2024FDA classification date |
| Boston Scientific AVVIGO+ Multi-Modality Guidance System, AVVIGO + MOB SYSTEM - ZERO COST JAPAN; the system utilizes an interactive display to pr…Z-0102-2025 · DQK | Boston Scientific Corporation | Recall | Oct 16, 2024FDA classification date |
| Boston Scientific AVVIGO+ Multi-Modality Guidance System, AVVIGO + MOB SYSTEM - ZERO COST US; the system utilizes an interactive display to provi…Z-0103-2025 · DQK | Boston Scientific Corporation | Recall | Oct 16, 2024FDA classification date |
| Boston Scientific AVVIGO+ Multi-Modality Guidance System, AVVIGO + MOB SYSTEM EU + ROW; the system utilizes an interactive display to provide phy…Z-0104-2025 · DQK | Boston Scientific Corporation | Recall | Oct 16, 2024FDA classification date |
| Boston Scientific AVVIGO+ Multi-Modality Guidance System, AVVIGO + MOB SYSTEM EVAL - ZERO COST US; the system utilizes an interactive display to …Z-0105-2025 · DQK | Boston Scientific Corporation | Recall | Oct 16, 2024FDA classification date |
| Boston Scientific AVVIGO+ Multi-Modality Guidance System, AVVIGO + MOB SYSTEM EVAL EU + ROW; the system utilizes an interactive display to provid…Z-0106-2025 · DQK | Boston Scientific Corporation | Recall | Oct 16, 2024FDA classification date |
| Boston Scientific AVVIGO+ Multi-Modality Guidance System, AVVIGO + MOB SYSTEM EVAL US; the system utilizes an interactive display to provide phys…Z-0107-2025 · DQK | Boston Scientific Corporation | Recall | Oct 16, 2024FDA classification date |
| Boston Scientific AVVIGO+ Multi-Modality Guidance System, AVVIGO + MOB SYSTEM JAPAN; the system utilizes an interactive display to provide physic…Z-0108-2025 · DQK | Boston Scientific Corporation | Recall | Oct 16, 2024FDA classification date |
| Boston Scientific AVVIGO+ Multi-Modality Guidance System, AVVIGO + MOB SYSTEM US; the system utilizes an interactive display to provide physician…Z-0109-2025 · DQK | Boston Scientific Corporation | Recall | Oct 16, 2024FDA classification date |
| Boston Scientific AVVIGO+ Multi-Modality Guidance System, AVVIGO II TO AVVIGO + INT Z UPGRADE JP; the system utilizes an interactive display to p…Z-0110-2025 · DQK | Boston Scientific Corporation | Recall | Oct 16, 2024FDA classification date |
| Boston Scientific AVVIGO+ Multi-Modality Guidance System, AVVIGO II TO AVVIGO + MOB Z UPGRADE JP; the system utilizes an interactive display to p…Z-0111-2025 · DQK | Boston Scientific Corporation | Recall | Oct 16, 2024FDA classification date |
| Boston Scientific AVVIGO+ Multi-Modality Guidance System, AVVIGO II TO AVVIGO INT UPGRADE JAPAN; the system utilizes an interactive display to pr…Z-0112-2025 · DQK | Boston Scientific Corporation | Recall | Oct 16, 2024FDA classification date |
| Boston Scientific AVVIGO+ Multi-Modality Guidance System, AVVIGO II TO AVVIGO INT UPGRADE US; the system utilizes an interactive display to provi…Z-0113-2025 · DQK | Boston Scientific Corporation | Recall | Oct 16, 2024FDA classification date |
| Boston Scientific AVVIGO+ Multi-Modality Guidance System, AVVIGO II TO AVVIGO MOB UPGRADE EU ROW; the system utilizes an interactive display to p…Z-0114-2025 · DQK | Boston Scientific Corporation | Recall | Oct 16, 2024FDA classification date |
| Boston Scientific AVVIGO+ Multi-Modality Guidance System, AVVIGO II TO AVVIGO MOB UPGRADE JAPAN; the system utilizes an interactive display to pr…Z-0115-2025 · DQK | Boston Scientific Corporation | Recall | Oct 16, 2024FDA classification date |
| Boston Scientific AVVIGO+ Multi-Modality Guidance System, AVVIGO II TO AVVIGO MOB UPGRADE US; the system utilizes an interactive display to provi…Z-0116-2025 · DQK | Boston Scientific Corporation | Recall | Oct 16, 2024FDA classification date |
| WALLFLEX FC ESO STENT RMV 18X103MM- Wallflex Esophageal Partially Covered (PC) and Fully Covered (FC) Stent System Intended for maintaining esoph…Z-3265-2024 · ESW | Boston Scientific Corporation | Recall | Sep 26, 2024FDA classification date |
| WALLFLEX FC ESO STENT RMV 18X123MM-Wallflex Esophageal Partially Covered (PC) and Fully Covered (FC) Stent System Intended for maintaining esopha…Z-3266-2024 · ESW | Boston Scientific Corporation | Recall | Sep 26, 2024FDA classification date |
| WALLFLEX FC ESO STENT RMV 18X153MM-Wallflex Esophageal Partially Covered (PC) and Fully Covered (FC) Stent System Intended for maintaining esopha…Z-3267-2024 · ESW | Boston Scientific Corporation | Recall | Sep 26, 2024FDA classification date |
| WALLFLEX FC ESO STENT RMV 23X105MM- Wallflex Esophageal Partially Covered (PC) and Fully Covered (FC) Stent System Intended for maintaining esoph…Z-3268-2024 · ESW | Boston Scientific Corporation | Recall | Sep 26, 2024FDA classification date |
| WALLFLEX FC ESO STENT RMV 23X125MM- Wallflex Esophageal Partially Covered (PC) and Fully Covered (FC) Stent System Intended for maintaining esoph…Z-3269-2024 · ESW | Boston Scientific Corporation | Recall | Sep 26, 2024FDA classification date |
| WALLFLEX FC ESO STENT RMV 23X155MM- Wallflex Esophageal Partially Covered (PC) and Fully Covered (FC) Stent System Intended for maintaining esoph…Z-3270-2024 · ESW | Boston Scientific Corporation | Recall | Sep 26, 2024FDA classification date |